Research even suggests it can change users' sense of smell, and other common side effects include diarrhoea, nausea, 'sulphur ...

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

After a blood test during her annual physical uncovered low hemoglobin levels, she underwent numerous tests and learned she had Stage 3 colorectal cancer. “They found a softball- and golf ball ...

The data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal ...

These meds go by the brand names Ozempic, Wegovy and Mounjaro ... Keeping a healthy weight as an adult decreases cardiometabolic risk factors and may extend lifespan. Semaglutide is a powerful tool ...

Ozempic and Wegovy, medications that have become increasingly popular this year due to their weight loss effects, were both tested on a monkey species listed as endangered, according to a National ...

Recent research suggests that Ozempic and other GLP-1 receptor agonists, commonly used for weight loss, may offer unexpected anti-cancer benefits, particularly for obesity-related cancers. Studies ...

Recent studies suggest that popular weight loss drugs like Ozempic may offer surprising ... evidence linking weight loss to a decreased risk of cancer, this study suggests that the injections ...